Harmony Biosciences Holdings (HRMY) EPS (Weighted Average and Diluted) Growth (3y) (2022 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -25,782.97% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 41.33% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 14.33% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -1.99% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 45.47% |
| 10 | Harmony Biosciences Holdings | 1.83 Bn | 1.19 Bn | 170.88 Mn | 4.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.64% |
| Dec 31, 2025 | -20.97% |
| Sep 30, 2025 | -15.46% |
| Jun 30, 2025 | 20.36% |
| Mar 31, 2025 | 30.62% |
| Dec 31, 2024 | 30.78% |
| Sep 30, 2024 | 88.02% |
| Jun 30, 2024 | -5.90% |
| Mar 31, 2024 | 72.73% |
| Dec 31, 2023 | -35.41% |
| Sep 30, 2023 | 86.63% |
| Jun 30, 2023 | 34.22% |
| Mar 31, 2023 | 27.57% |
| Dec 31, 2022 | 28.73% |
| Sep 30, 2022 | 31.50% |